Vicki Seyfert-Margolis, Ph.D.
CEO and Founder | RespondHealth, Inc.
Professional Overview
Vicki Seyfert-Margolis, Ph.D., is a seasoned healthcare leader with extensive expertise in the pharmaceutical and biotechnology industries. As the CEO and Founder of RespondHealth, Inc. (formerly My Own Med, Inc.), she is spearheading innovative solutions that empower patients and drive advancements in precision medicine.
Experience Summary
Current Role
As the CEO and Founder of RespondHealth, Inc., Dr. Seyfert-Margolis is responsible for driving the company's strategic vision and overseeing all aspects of its operations. Under her leadership, RespondHealth has emerged as a trailblazer in the field of personalized healthcare, developing cutting-edge technologies that enhance patient engagement and decision-making.
Career Progression
Prior to founding RespondHealth, Dr. Seyfert-Margolis served as the Chief Science and Strategy Officer at Precision Health Holdings, where she played a pivotal role in shaping the company's strategic direction. She also held the position of Senior Advisor Science in the Office of the Commissioner at the Food and Drug Administration (FDA), where she made significant contributions to the agency's efforts in advancing regulatory science and precision medicine initiatives.
Earlier in her career, Dr. Seyfert-Margolis served as the Chief Science Officer at the Immune Tolerance Network, where she spearheaded groundbreaking research and collaborations aimed at developing novel immunotherapies.
Academic Background
Dr. Seyfert-Margolis holds a Ph.D. in Immunology from the University of Pennsylvania, where she conducted extensive research in the field of immune system regulation and tolerance.
Areas of Expertise
- Precision medicine and personalized healthcare
- Regulatory science and policy development
- Immunology and immunotherapy
- Strategic planning and business development
- Collaborative leadership and stakeholder engagement
Professional Impact
Under Dr. Seyfert-Margolis's leadership, RespondHealth has become a prominent player in the personalized healthcare landscape, leveraging cutting-edge technologies to empower patients and healthcare providers. Her contributions to the FDA's regulatory science initiatives have helped shape the agency's approach to precision medicine, while her work at the Immune Tolerance Network has advanced the understanding and treatment of autoimmune and inflammatory disorders.
Conclusion
With her vast experience, innovative mindset, and a steadfast commitment to improving patient outcomes, Dr. Vicki Seyfert-Margolis is a respected leader in the healthcare industry. As the CEO and Founder of RespondHealth, she continues to drive transformative change, positioning the company as a pioneer in the field of personalized medicine.
